Noul's miLab registered FDA's Class I

South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said on ...
South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said on ...
South Korean in-vitro diagnostics maker Noul Co. has signed an exclusive sales deal in Angola on the company’s malaria diagnostic platform wor...
Noul Co., a South Korean company specializing in artificial intelligence (AI)-based blood and cancer diagnostic platforms, has entered the cancer di...